FDA panel considers easing peptide restrictions

The FDA's advisory panel is examining seven peptides, with NPR reporting that advisers are weighing whether current restrictions should be eased. Favorable votes would clear the path for broader access to these treatments.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton